🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study evaluates the long-term safety and efficacy of elexacaftor (ELX)/...
Status
Completed
Location
Telethon Kids Institute
Start Date
2021-01-11
Trial ID
NCT04545515
Treatments Being Tested
This is a prospective, single-center, fixed-sequence, nonrandomized, open-l...
Status
Completed
Location
University of Southern California
Start Date
2022-05-09
Trial ID
NCT04840862
Treatments Being Tested
This study was evaluate the effect of elexacaftor (ELX)/tezacaftor (TEZ)/iv...
Status
Completed
Location
Royal Adelaide Hospital
Start Date
2021-01-15
Trial ID
NCT04599465
Treatments Being Tested
Observational study on women with Cystic Fibrosis treated with CFTR modulat...
Status
Recruiting
Location
Stockholm CF center
Start Date
2024-03-15
Trial ID
NCT06302270
The purpose of the study is to evaluate the long-term safety, tolerability,...
Status
Active Not Recruiting
Location
The Kids Research Institute Australia
Start Date
2024-11-21
Trial ID
NCT06460506
Treatments Being Tested
RECOVER is a prospective, multicenter observational study designed to measu...
Status
Active Not Recruiting
Location
Children's Health Ireland at Crumlin
Start Date
2020-09-03
Trial ID
NCT04602468
Treatments Being Tested
The study aims to test whether use of CFTR modulators (ETI) improves fastin...
Status
Enrolling By Invitation
Location
University of Alabama at Birmingham
Start Date
2026-05-28
Trial ID
NCT07102043
The development of CFTR (cystic fibrosis conductance transmembrane regulato...
Status
Completed
Location
Hopitaux Universitaires de Strasbourg
Start Date
2024-04-08
Trial ID
NCT06331000
Treatments Being Tested
The goal of this observational study is to provide optimal monitoring and s...
Status
Unknown
Location
Lebecque
Start Date
2022-09-01
Trial ID
NCT05599230
Cystic fibrosis (CF) is associated with major pharmacokinetic and pharmacod...
Status
Recruiting
Location
Fondation ILDYS
Start Date
2026-03-19
Trial ID
NCT07629986
Treatments Being Tested